Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation - sprookjes - yvandenbroek - TriplyDB

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation

http://www.wikidata.org/entity/Q28393303

about

Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections Exported Epoxide Hydrolases Modulate Erythrocyte Vasoactive Lipids during Plasmodium falciparum Infection Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway Epoxyeicosatrienoic acids and cardioprotection: the road to translation Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism EET signaling in cancer Inside epoxyeicosatrienoic acids and cardiovascular disease Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients Sexually dimorphic phenotype of arteriolar responsiveness to shear stress in soluble epoxide hydrolase-knockout mice Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy.Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.PPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.CYP2C29 produces superoxide in response to shear stress.Vascular pharmacology of epoxyeicosatrienoic acids Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation.Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice.Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.Cell biology of ischemia/reperfusion injury.

P2860

Q24618018-1BF3ADF2-4F58-402B-A23C-60EE3E681847 Q26825122-F9FAE14F-B8B4-40BB-A1C6-F29901EE5406 Q27974556-EEF91F73-A283-4A67-9365-96B0346A692D Q28235974-5D0FC99D-E0CB-4E23-8833-1F03BA5F11A8 Q28241262-5AD20D76-4891-4EF9-BED4-57C5466EDB71 Q28245279-B54F76F7-7253-46E5-A811-12195D16D542 Q28250730-D3A8F23C-9585-49CF-89DA-1906975FBC73 Q28252156-AD9E8E58-D87F-44DF-A450-2EF48D38E622 Q28383719-284A64C4-4ED0-444B-8AD9-45382984DE49 Q28384214-9402FBF9-3D6F-4AD7-AE99-04DC0315A757 Q28384901-1A53859E-D7B8-4AD8-AEAF-32A821A3A85B Q28385478-CBDCFE05-9E49-4303-B4C1-47D46B343C57 Q28385509-44D8FD63-23C8-48E3-AB07-781094AC74DB Q28385835-E6DEA1E7-1418-4B97-85BB-5541EEA58D12 Q28397330-FECD6896-B9C1-4AA0-B798-23CD93CD7C32 Q28397434-7DD34355-2CB9-4CB1-B7FA-AEBEB924DC24 Q28398002-F9AD9128-D02E-486A-9333-BA42B7B88FCC Q33638451-F4459222-8964-4F09-8202-0F32981BC2BC Q33738489-22B3B14D-383C-4259-AF02-8734B708DBE7 Q33852943-A55412E8-3175-4E2D-9A3D-8926F3172D7F Q33930304-B963F2C2-11B6-401C-9AB1-6E7640021A55 Q34035269-579F6045-2CD0-440D-8BEE-BF13E1B094BF Q34143118-C6CFE9BB-93F4-405D-9BB8-51B79C0C0BCB Q34238703-E205B243-0CCC-499F-98C7-B7C4C3883E7F Q34332185-DC988BE9-1091-4DB1-966F-E6686E8CF522 Q34378817-5A494722-A1F7-44C9-B1D0-865B2D7A55AB Q34488280-83BE4CBD-35E0-48CC-A952-F6E8472A5164 Q34986906-A19F084A-98E6-4108-B19F-1939501EE515 Q35849378-F346489D-2A78-4010-8781-45BBF71FCFE5 Q35997888-53EDDF53-9960-4774-94FA-4A30BA4EE0CD Q36027183-E72F50D6-7C22-4675-9BE0-66FF23771A1E Q36199024-A2DD84D1-B6BC-4D03-909E-448DC844B8AD Q36202208-57889937-03FA-4A94-B374-7177DC6FFBDF Q36382133-C0927328-CE5C-4B88-B0E0-FBF7232765C5 Q36527885-925A0680-FC64-44BA-940C-EA7E0E739A45 Q36545303-D58D58F0-9C51-4C64-94B9-930A3AB2F563 Q37170684-9769FC4B-3019-4B86-BB04-A6EFA2D1B5A8 Q37225813-157B7A1C-F16F-427F-9CE6-959BE48E6FD3 Q37439850-018C20B5-4222-4E3E-BF9A-C71C30DFA63A Q37524901-F996EE3C-0F81-4301-8FE8-5C3EF12DC276

P2860

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation

http://www.wikidata.org/entity/Q28393303

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@ast

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@en

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@nl

type

label

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@ast

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@en

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@nl

prefLabel

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@ast

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@en

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@nl

P1433

Q28393303-08F8DBA2-65AF-41D6-AC72-8088D801CEE8

P1476

Q28393303-10EE8A96-1B5F-437F-A87D-80FA91378DD8

P2093

Q28393303-6061268E-AE41-40FA-A705-269CD031FB00

Q28393303-72639D8F-36FF-4DE1-8D6B-E1307BEB3E05

Q28393303-CA0BFC1A-4E80-4960-98E2-1505C13E4D73

P2860

Q28393303-00262AE2-40A8-45DC-BA36-28379D8FD37D

Q28393303-01A04AE6-2F3B-4EE2-9E0C-8D2DD005DE13

Q28393303-037EAB40-83A6-41E8-81F0-444B0F3E68EE

Q28393303-03ACF3CE-EFD7-407C-A481-1807FAD3DD9A

Q28393303-04529AC5-5720-4516-9CE5-5C2A903115E2

Q28393303-05779962-7FF9-48DC-B670-272B5279E674

Q28393303-0D0B0574-F430-4F47-AEEB-52726D9E60B2

Q28393303-0DC9BF62-42B2-42FB-9156-E254FEDF0F74

Q28393303-10AF73E7-6511-4B5D-B2D8-6846ACFB6C0F

Q28393303-11692D0C-5364-4D35-8E13-12F4C4B4A2C5

P304

Q28393303-03330286-8058-4CA1-B5BF-ED3AEA94698B

P31

Q28393303-A98B8716-92E1-4E56-8AED-B62A0137379D

P3181

Q28393303-8ACD8C2B-4FF4-4E19-9C45-8C3A4E69A3A8

P356

Q28393303-9CDA7DB0-97BB-47CD-BDDA-098031D64F5F

P407

Q28393303-C7D04A00-31DB-4C3A-91FF-DDC0D18AC080

P433

Q28393303-6187656D-DFBA-4D61-B24D-8444B05B9C26

P478

Q28393303-2ABCE4C3-F541-4753-B53F-A18842D4501A

P577

Q28393303-BEBEEFC6-ACF2-4E03-8BD6-32D8620B4CD3

P5875

Q28393303-15B1F246-A2A2-487E-9CBC-08BA049668EA

P698

Q28393303-4BAAA75A-BEBE-4DD5-91E5-E0456F9D8DA2

P921

Q28393303-0E3DE39C-3EA6-4795-9C5A-ED96122CB257

Q28393303-CB0676BA-7F1C-462B-A493-2FA274C59068

P932

Q28393303-9B1DA20C-4AAC-4AEA-930D-5C9703DA4AB5

P3181

P356

J.YJMCC.2009.10.022

P1433

Journal of Molecular and Cellular Cardiology

P1476

Cytochrome P450 epoxygenases, ...... of cardiovascular inflammation

@en

P2093

Craig R Lee

http://www.w3.org/2001/XMLSchema#string

Katherine N Theken

http://www.w3.org/2001/XMLSchema#string

Yangmei Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury

Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

P304

331-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2927777

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.YJMCC.2009.10.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38069499

http://www.w3.org/2001/XMLSchema#string

P698

19891972

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2813356

http://www.w3.org/2001/XMLSchema#string